These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30170755)

  • 21. Telavancin for refractory methicillin-resistant Staphylococcus aureus bacteremia and infective endocarditis.
    Ruggero MA; Peaper DR; Topal JE
    Infect Dis (Lond); 2015 Jun; 47(6):379-84. PubMed ID: 25746601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections.
    Lu KY; Wagner NJ; Velez AZ; Ceppe A; Conlon BP; Muhlebach MS
    Microbiol Spectr; 2023 Feb; 11(1):e0406122. PubMed ID: 36519944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative agents to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Culos KA; Cannon JP; Grim SA
    Am J Ther; 2013; 20(2):200-12. PubMed ID: 21642833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous infusion vancomycin for treatment of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients.
    Fung L
    Ann Pharmacother; 2012 Oct; 46(10):e26. PubMed ID: 23032658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating Central Catheter-Associated Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Beyond Vancomycin.
    Holt S; Thompson-Brazill KA; Sparks ER; Lipetzky J
    Crit Care Nurse; 2016 Aug; 36(4):46-57. PubMed ID: 27481801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telavancin in vitro activity against a collection of methicillin-resistant Staphylococcus aureus isolates, including resistant subsets, from the United States.
    Mendes RE; Sader HS; Flamm RK; Farrell DJ; Jones RN
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1811-4. PubMed ID: 25561335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.
    Champion EA; Miller MB; Popowitch EB; Hobbs MM; Saiman L; Muhlebach MS;
    Pediatr Pulmonol; 2014 Mar; 49(3):230-7. PubMed ID: 23765686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model.
    Yin LY; Calhoun JH; Thomas TS; Wirtz ED
    J Antimicrob Chemother; 2009 Feb; 63(2):357-60. PubMed ID: 19060292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.
    Stockmann C; Sherwin CM; Zobell JT; Lubsch L; Young DC; Olson J; Noyes BE; Ampofo K; Spigarelli MG
    Pharmacotherapy; 2013 Dec; 33(12):1288-96. PubMed ID: 23824677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples.
    Pahadi PC; Shrestha UT; Adhikari N; Shah PK; Amatya R
    JNMA J Nepal Med Assoc; 2014; 52(196):977-81. PubMed ID: 26982895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telavancin: mechanisms of action, in vitro activity, and mechanisms of resistance.
    Karlowsky JA; Nichol K; Zhanel GG
    Clin Infect Dis; 2015 Sep; 61 Suppl 2():S58-68. PubMed ID: 26316559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes and Treatment of Chronic Methicillin-Resistant Staphylococcus aureus Differs by Staphylococcal Cassette Chromosome mec (SCCmec) Type in Children With Cystic Fibrosis.
    Heltshe SL; Saiman L; Popowitch EB; Miller MB; Kloster M; Thompson V; Ferkol TW; Hoover WC; Schechter MS; Muhlebach MS
    J Pediatric Infect Dis Soc; 2015 Sep; 4(3):225-31. PubMed ID: 26336603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy of telavancin and daptomycin in experimental endocarditis due to multi-clonotype MRSA strains.
    Xiong YQ; Abdelhady W; Tang C'; Bayer AS
    J Antimicrob Chemother; 2016 Oct; 71(10):2890-4. PubMed ID: 27353467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
    Madrigal AG; Basuino L; Chambers HF
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of Phase 3 telavancin nosocomial pneumonia data excluding patients with severe renal impairment and acute renal failure.
    Torres A; Rubinstein E; Corey GR; Stryjewski ME; Barriere SL
    J Antimicrob Chemother; 2014 Apr; 69(4):1119-26. PubMed ID: 24398339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
    Segarra-Newnham M; Church TJ
    Ann Pharmacother; 2012 Dec; 46(12):1678-87. PubMed ID: 23232021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia.
    Haque NZ; Zuniga LC; Peyrani P; Reyes K; Lamerato L; Moore CL; Patel S; Allen M; Peterson E; Wiemken T; Cano E; Mangino JE; Kett DH; Ramirez JA; Zervos MJ;
    Chest; 2010 Dec; 138(6):1356-62. PubMed ID: 20558550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predominance of hospital-associated MRSA among cystic fibrosis patients in a Turkish reference cystic fibrosis centre.
    Yurdakul P; Ocal HY; Gulmez D; Yalcin E; Dogru D; Cinel G; Özcelik U; Kiper N; Sener B
    J Chemother; 2012 Aug; 24(4):195-200. PubMed ID: 23040682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Effectiveness of Vancomycin Versus Linezolid for the Treatment of Acute Pulmonary Exacerbations of Cystic Fibrosis.
    Fusco NM; Meaney CJ; Frederick CA; Prescott WA
    Ann Pharmacother; 2020 Mar; 54(3):197-204. PubMed ID: 31658825
    [No Abstract]   [Full Text] [Related]  

  • 40. Vancomycin, unbeatable for methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia? Really?
    Luna CM; Bruno D; Aruj P
    Crit Care Med; 2010 Sep; 38(9):1910-2. PubMed ID: 20724890
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.